PharmiWeb.com - Global Pharma News & Resources
23-Aug-2022

Asia Pacific Pain Management Therapeutics Market Emerging Trend, Top Companies, Industry Demand and Regional Analysis

Potential tissue damage results in pain, which is an excruciatingly unpleasant sensory and emotional experience. Pharmaceuticals from many therapeutic classes, including antidepressants, opioids, NSAIDs, anticonvulsants, anaesthetics, and other non-narcotic analgesics, are frequently used as the first line of treatment for pain management.

Pain is typically described as a distressing sensory and emotional experience that primarily originates from disease or tissue damage.

Numerous diseases, such as osteoarthritis, cancer, multiple sclerosis, stomach ulcers, diabetic neuropathy, fibromyalgia, and chronic arthritis, can result in discomfort.

Acute pain with a short-term goal and chronic pain with a long-term goal are two different types of pain that can last. Injuries, nerve damage, and aging-related bone and joint disorders are the main causes of persistent pain.

The prevalence of cancer, increase in operations, and rising investment in the discovery of new pain medications are all contributing to the huge growth of the pain management therapeutics market. Around the world, chronic pain and high-impact chronic pain are becoming more common.

 

Asia Pacific Pain Management Therapeutics Market- Key Market Trends

 

  • Rising adoption of opioids in the market

One of the major factor that has fuelled the market growth over the forecast period is the rising adoption of opioids in the market. The companies have started replacing for the use of opioids that has boosted the market growth.

  • Approval, as well as the launch of new therapeutics, have boosted the market

Another factor that has boosted the market growth over the forecast period is the approval as well as the launch of new therapeutics in the market. These have resulted in the use for adults in certified medically supervised healthcare settings for the management of acute pain severe enough to require an opioid analgesic.

Additionally, rising prevalence of arthritis is also projected to aid the market growth over the forecast period. Such as, an estimated 54.4 million US adults have diagnosed arthritis that have accounted for around 1 in 4 people in the U.S., according to the Centres for Disease Control and Prevention (CDC)’s May 2019 report.

 

Get Free Sample:- https://wemarketresearch.com/sample-request/asia-pacific-pain-management-therapeutics-market/160/

 

Asia Pacific Pain Management Therapeutics Market- Segmental analysis

 

Based on Therapeutics
• Anaesthetics
• Anticonvulsant
• Antidepressant Drugs
• Anti-Migraine Drugs
• Opioids
• Others

Based on Indication
• Arthritic Pain
• Neuropathic Pain
• Cancer Pain
• Chronic Pain
• Post-Operative Pain
• Migraine
• Fibromyalgia
• Bone Fracture
• Muscle Sprain/Strain
• Acute Appendicitis
• Other Indications

Based on Distribution Channel
• Online pharmacy
• Retail pharmacy
• Hospital pharmacy

Major Key Players 

  • Pfizer Inc.
  • Novartis AG
  • Sanofi S.A
  • Teva Pharmaceutical Industries Ltd
  • Merck & Co. Inc.
  • Baxter International Inc.
  • WEX Pharmaceuticals
  • Abbott Laboratories
  • Zynerba Pharmaceuticals
  • Boehringer Ingelheim
  • GlaxoSmithKline plc
  • Sorrento Therapeutics
  • Johnson & Johnson Services Inc.
  • Purdue Pharma L.P.
  • Bristol-Myers Squibb Company
  • Endo Health Solutions Inc.
  • Eli Lilly and Company
  • Valeant Pharmaceuticals International Inc.
  • Allergen Inc.
  • Mylan NV

Get more details on this report:-  https://wemarketresearch.com/reports/asia-pacific-pain-management-therapeutics-market/160/

Frequently Asked Questions

  1. What is pain management therapeutics?
  2. What is the CAGR of pain management therapeutics market?
  3. What are the factors driving the pain management therapeutics market?
  4. Which region is accounted for the largest pain management therapeutics market share?
  5. Which segment accounted for the largest healthcare staffing market share?
  6. Which major companies are operating in the pain management therapeutics market?

About Us WE MARKET RESEARCH

WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

Contact Us:

We Market Research

Phone: +1(929)-450-2887

Email: sales@wemarketresearch.com

Editor Details

Last Updated: 23-Aug-2022